CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 769 of 870
Non-Antibody Products
Page 769 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| SR 95531 (hydrobromide) | A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… | 25 mg | 14585-25 | More Info |
| SR 95531 (hydrobromide) | A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… | 5 mg | 14585-5 | More Info |
| SR 95531 (hydrobromide) | A derivative of GABA that acts as an antagonist of GABAA receptors (Ki = 7… | 50 mg | 14585-50 | More Info |
| SR 142948 (hydrochloride) | A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… | 1 mg | 23911-1 | More Info |
| SR 142948 (hydrochloride) | A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… | 10 mg | 23911-10 | More Info |
| SR 142948 (hydrochloride) | A neurotensin receptor antagonist (IC50s = 1.19, 0.32, and 3.96 nM for hum… | 5 mg | 23911-5 | More Info |
| SR 1555 (hydrochloride) | A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… | 1 mg | 12071-1 | More Info |
| SR 1555 (hydrochloride) | A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… | 10 mg | 12071-10 | More Info |
| SR 1555 (hydrochloride) | A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… | 25 mg | 12071-25 | More Info |
| SR 1555 (hydrochloride) | A selective ligand of RORγ (IC50 = 1 µM); does not bind ROR&al… | 5 mg | 12071-5 | More Info |
| (1S,3R)-3-Hydroxycyclopentane acetic acid | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11382-50 | More Info |
| (1S,3R)-3-Hydroxycyclopentane acetic acid methyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11386-50 | More Info |
| (1S,3R)-3-Hydroxycyclopentane carboxylic acid methyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11375-50 | More Info |
| SRI-011381 | An activator of TGF-β signaling; reduces increases in Aβ42-induc… | 1 mg | 28914-1 | More Info |
| SRI-011381 | An activator of TGF-β signaling; reduces increases in Aβ42-induc… | 10 mg | 28914-10 | More Info |
| SRI-011381 | An activator of TGF-β signaling; reduces increases in Aβ42-induc… | 5 mg | 28914-5 | More Info |
| SRI-011381 | An activator of TGF-β signaling; reduces increases in Aβ42-induc… | 500 µg | 28914-500 | More Info |
| SRI-37330 | A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… | 1 mg | 31638-1 | More Info |
| SRI-37330 | A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… | 10 mg | 31638-10 | More Info |
| SRI-37330 | A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… | 25 mg | 31638-25 | More Info |
| SRI-37330 | A TXNIP inhibitor; inhibits the expression of Txnip mRNA in INS-1 cells (I… | 5 mg | 31638-5 | More Info |
| SR 717 (lithium salt) | A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… | 10 mg | 31759-10 | More Info |
| SR 717 (lithium salt) | A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… | 25 mg | 31759-25 | More Info |
| SR 717 (lithium salt) | A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… | 5 mg | 31759-5 | More Info |
| SR 717 (lithium salt) | A STING agonist (EC50 = 2.1 µM in a reporter assay); selective for S… | 50 mg | 31759-50 | More Info |
| SRPIN340 | An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… | 1 mg | 16284-1 | More Info |
| SRPIN340 | An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… | 10 mg | 16284-10 | More Info |
| SRPIN340 | An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… | 25 mg | 16284-25 | More Info |
| SRPIN340 | An inhibitor of SRPK1 (Ki = 0.89 µM); suppresses the propagation of… | 5 mg | 16284-5 | More Info |
| (1S,3R)-RSL3 | A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… | 1 mg | 19288-1 | More Info |
| (1S,3R)-RSL3 | A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… | 10 mg | 19288-10 | More Info |
| (1S,3R)-RSL3 | A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… | 25 mg | 19288-25 | More Info |
| (1S,3R)-RSL3 | A ferroptosis inducer; inhibits GPX4 in a context-dependent manner; inhibi… | 5 mg | 19288-5 | More Info |
| SRS11-92 | A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… | 1 mg | 25689-1 | More Info |
| SRS11-92 | A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… | 10 mg | 25689-10 | More Info |
| SRS11-92 | A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… | 25 mg | 25689-25 | More Info |
| SRS11-92 | A ferroptosis inhibitor and a derivative of ferrostatin-1; inhibits ferrop… | 5 mg | 25689-5 | More Info |
| SRS16-86 | An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… | 1 mg | 26752-1 | More Info |
| SRS16-86 | An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… | 5 mg | 26752-5 | More Info |
| SRS16-86 | An inhibitor of ferroptosis; inhibits erastin-induced ferroptosis in HT-10… | 500 µg | 26752-500 | More Info |
| SRT 2104 | A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… | 1 mg | 28380-1 | More Info |
| SRT 2104 | A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… | 10 mg | 28380-10 | More Info |
| SRT 2104 | A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… | 25 mg | 28380-25 | More Info |
| SRT 2104 | A SIRT1 activator; increases renal SIRT1 activity and protein levels and d… | 5 mg | 28380-5 | More Info |
| SRT 1720 (hydrochloride) | A selective small molecule activator of SIRT1 that is 1,000-fold more pote… | 1 mg | 10011020-1 | More Info |
| SRT 1720 (hydrochloride) | A selective small molecule activator of SIRT1 that is 1,000-fold more pote… | 10 mg | 10011020-10 | More Info |
| SRT 1720 (hydrochloride) | A selective small molecule activator of SIRT1 that is 1,000-fold more pote… | 5 mg | 10011020-5 | More Info |
| SRT 1720 (hydrochloride) | A selective small molecule activator of SIRT1 that is 1,000-fold more pote… | 50 mg | 10011020-50 | More Info |
| SRT 3025 (hydrochloride) | A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… | 10 mg | 34420-10 | More Info |
| SRT 3025 (hydrochloride) | A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… | 100 mg | 34420-100 | More Info |
| SRT 3025 (hydrochloride) | A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… | 250 mg | 34420-250 | More Info |
| SRT 3025 (hydrochloride) | A SIRT1 activator; increases SIRT1 levels in, and inhibits RANKL-induced o… | 50 mg | 34420-50 | More Info |
| 5(S),6(R)-11-trans DiHETE | 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… | 100 µg | 10009628-100 | More Info |
| 5(S),6(R)-11-trans DiHETE | 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… | 25 µg | 10009628-25 | More Info |
| 5(S),6(R)-11-trans DiHETE | 5(S),6(R)-11-trans DiHETE is a C-11 double bond isomer of 5(S),6(R)-DiHETE… | 50 µg | 10009628-50 | More Info |
| 5(S),6(R)-7-trihydroxymethyl Heptanoate | A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… | 1 mg | 10005032-1 | More Info |
| 5(S),6(R)-7-trihydroxymethyl Heptanoate | A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… | 10 mg | 10005032-10 | More Info |
| 5(S),6(R)-7-trihydroxymethyl Heptanoate | A potent bioactive analog of lipoxin A4; inhibits LTB4-induced chemotaxis… | 5 mg | 10005032-5 | More Info |
| SS-208 | An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… | 1 mg | 29128-1 | More Info |
| SS-208 | An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… | 10 mg | 29128-10 | More Info |
| SS-208 | An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… | 25 mg | 29128-25 | More Info |
| SS-208 | An HDAC6 inhibitor (IC50 = 12 nM); selective for HDAC6 over HDAC1, -4, -5,… | 5 mg | 29128-5 | More Info |
| SSAA09E1 | A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… | 1 mg | 32582-1 | More Info |
| SSAA09E1 | A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… | 10 mg | 32582-10 | More Info |
| SSAA09E1 | A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… | 25 mg | 32582-25 | More Info |
| SSAA09E1 | A SARS-CoV entry inhibitor; reduces infection of HEK293T cells transiently… | 5 mg | 32582-5 | More Info |
| (1S,3S)-3-Aminomethyl-cyclopentanol | A synthetic intermediate useful for pharmaceutical synthesis | 50 mg | 11358-50 | More Info |
| (3S,5S)-Atorvastatin (sodium salt) | An enantiomer of atorvastatin that has little or no inhibitory activity ag… | 1 mg | 18465-1 | More Info |
| (3S,5S)-Atorvastatin (sodium salt) | An enantiomer of atorvastatin that has little or no inhibitory activity ag… | 10 mg | 18465-10 | More Info |
| (3S,5S)-Atorvastatin (sodium salt) | An enantiomer of atorvastatin that has little or no inhibitory activity ag… | 5 mg | 18465-5 | More Info |
| (1S,3S)-3-Benzoic acid 3-carboxycyclopentyl ester | A synthetic intermediate useful for pharmaceutical synthesis. | 50 mg | 11364-50 | More Info |
| 10(S),17(S)-DiHDHA | A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… | 100 µg | 10008128-100 | More Info |
| 10(S),17(S)-DiHDHA | A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… | 25 µg | 10008128-25 | More Info |
| 10(S),17(S)-DiHDHA | A DHA metabolite, also referred to as protectin DX (PDX), produced by an a… | 50 µg | 10008128-50 | More Info |
| 5(S),12(S)-DiHETE | A natural bioactive lipid derived from AA | 100 µg | 35260-100 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile